Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Released Aug 8, 2025, during market hours
10-Q filed Aug 8, 2025, 39 days after period end · 0001641172-25-022691
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $496.35K | $406.28K | $482.77K | $327.92K |
| Net Income | $23.89K | -$10.04K | $68.41K | -$99.01K |
| EPS Diluted |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
